Treatment strategy for hepatocellular carcinoma recurrence in the transplant era: Focusing on the Japan criteria.
Shohei YoshiyaNoboru HaradaTakeo ToshimaKatsuya ToshidaYukiko KosaiTakahiro TominoYoshihiro NagaoHiroto KayashimaShinji ItohTomoharu YoshizumiPublished in: Surgery today (2023)
Even for HCC recurrence, the JC could play an important role in deciding on the best treatment strategy, and downstaging within the JC had good post-transplant outcomes.
Keyphrases